Loading...
Basel Medical Group Ltd Ordinary Shares
BMGL•NASDAQ
Healthcare
Medical - Healthcare Plans
$0.68
$0.04(6.30%)
U.S. Market opens in 10h 45mBasel Medical Group Ltd Ordinary Shares (BMGL) AI-Powered Stock Analysis
See how Basel Medical Group Ltd Ordinary Shares scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBasel Medical Group Ltd Ordinary Shares (BMGL) Stock Overall Grade
Basel Medical Group Ltd Ordinary Shares’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Basel Medical Group Ltd Ordinary Shares's overall stock rating.
Forecast
C+Score
51/100Financial Growth
CScore
40/100Fundamental Growth
BScore
69/100Key Ratios
C+Score
52/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Basel Medical Group Ltd Ordinary Shares (BMGL) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 51/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (69/100, B) highlight its stability, while Key Ratios (52/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Basel Medical Group Ltd Ordinary Shares stock grade, including financials, comparisons, and forecasts.